Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
This phase I trial is studying the side effects and best dose of combination chemotherapy in
treating patients with metastatic or unresectable solid tumors. Drugs used in chemotherapy,
such as docetaxel and 17-N-allylamino-17-demethoxygeldanamycin, work in different ways to
stop tumor cells from dividing so they stop growing or die. Combining more than one drug may
kill more tumor cells.